Rigel Pharmaceuticals Inc (RIGL)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RIGL market cap is 292.42M. The company's latest EPS is USD 0.9788 and P/E is 16.72.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35.79M | 29.53M | 36.84M | 55.31M | 57.6M |
| Operating Income | 1.97M | -6.97M | 447k | 14.06M | 16.66M |
| Net Income | 737k | -8.25M | -1.03M | 12.42M | 14.34M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 108.62M | 149.24M | 120.24M | 116.88M | 179.28M |
| Operating Income | -28.97M | -12.5M | -55.55M | -20.49M | 24.19M |
| Net Income | -29.74M | -17.91M | -58.57M | -25.09M | 17.49M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 117.23M | 126.52M | 128.41M | 139.42M | 163.98M |
| Total Liabilities | 145.87M | 158.19M | 158.32M | 154.06M | 160.69M |
| Total Equity | -28.64M | -31.67M | -29.91M | -14.64M | 3.29M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 110.38M | 167.33M | 134.28M | 117.23M | 163.98M |
| Total Liabilities | 76.35M | 136.95M | 147.9M | 145.87M | 160.69M |
| Total Equity | 34.03M | 30.37M | -13.62M | -28.64M | 3.29M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.74M | -5.01M | -4.71M | 16.97M | 31.47M |
| Investing | -4.3M | 313k | 11.24M | 15.04M | 4.13M |
| Financing | 18.37M | -2.51M | -3.26M | -13.11M | -11.64M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -52.19M | 5.88M | -73.76M | -5.74M | 31.47M |
| Investing | 47.47M | -80.04M | 72.78M | -4.3M | 4.13M |
| Financing | 12.57M | 62.68M | 6.55M | 18.37M | -11.64M |
| Market Cap | 292.42M |
| Price to Earnings Ratio | 16.72 |
| Price to Sales Ratio | 1.63 |
| Price to Cash Ratio | 5.15 |
| Price to Book Ratio | 88.93 |
| Dividend Yield | - |
| Shares Outstanding | 17.86M |
| Average Volume (1 week) | 216.54k |
| Average Volume (1 Month) | 231.77k |
| 52 Week Change | 27.89% |
| 52 Week High | 29.82 |
| 52 Week Low | 7.4843 |
| Spread (Intraday) | 1.87 (10.99%) |
| Company Name | Rigel Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.rigel.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
